The affected product, which is packaged in vials and used for induction of anesthesia, was distributed to wholesalers and direct customers from September 2011 through February 2012.
The recall was caused by the potential for visible particles embedded in the glass to become dislodged into the solution. If this occurred, the matted could be injected into a patient and cause injuries.
More Articles on Recalls:
FDA Warns of Risk of Death From Codeine in Children Following Surgery
Covidien Initiates Voluntary Recall of Tracheostomy Tubes
St. Jude Medical Recalls Neurostimulation Device for Battery Issues
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
